PEOPLE - Possis Medical announces resignation:
This article was originally published in Clinica
Russel Carlson has resigned as chief financial officer of Possis Medical, to pursue other interests. The company's financial and accounting functions will report to CEO Roger Dutcher until a replacement is found.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.